Hostname: page-component-7479d7b7d-fwgfc Total loading time: 0 Render date: 2024-07-12T07:24:49.968Z Has data issue: false hasContentIssue false
  • English
  • Français

Critical care management of severe pre-eclampsia

Published online by Cambridge University Press:  10 October 2008

J Anthony ,
R Johanson  and
J Dommisse
J Anthony*
Affiliation:
Department of Obstetrics and Gynaecology, University of Cape Town, South Africa
R Johanson
Affiliation:
North Staffordshire Hospital, Stoke-on-Trent, UK
J Dommisse
Affiliation:
Department of Obstetrics and Gynaecology, University of Cape Town, South Africa
*
Dr J Anthony, Department of Obstetrics and Gynaecology, Medical School, Anzio Rd ObservatorySouth Africa7925
Get access Rights & Permissions [Opens in a new window]

Extract

Severe pre-eclampsia is a common disorder in developing countries but still remains a significant problem in developed societies. The management of severe pre-eclampsia in developing countries is frequently hampered by lack of adequate facilities; paradoxically those countries with sufficient resources have a lower incidence of the disease and consequently lack experience in the treatment of severe pre-eclampsia. The management of these patients is further compromised because obstetricians generally lack the necessary knowledge and skills in critical care and conversely critical care specialists may lack appreciation and knowledge of pregnancy physiology and pathophysiology. Patients with severe pre-eclampsia therefore present an interdisciplinary challenge to obstetricians and physicians, who need to be familiar with pregnancy physiology and the current concepts in the pathogenesis and pathophysiology of severe pre-eclampsia. Patients who develop multisystem disease are most appropriately managed by an experienced obstetrician in an obstetric intensive care unit with a physician in consultation.

Type
Articles
Information
Fetal and Maternal Medicine Review , Volume 6 , Issue 4 , November 1994 , pp. 219 - 229
Copyright
Copyright © Cambridge University Press 1994

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1Loudon, I. Some historical aspects of toxaemia of pregnancy. A review. Br J Obstet Gynaecol 1991; 98: 853–58.CrossRefGoogle ScholarPubMed
2Vane, JM, Anggard, EE, Botting, RM. Regulatory functions of the vascular endothelium. N Engl J Med 1990; 323: 27–36.Google ScholarPubMed
3Roberts, JM, Taylor, RN, Musci, TJ, Rodgers, GM, Hubel, CA, McLaughlin, MK. Preeclampsia: an endothelial cell disorder. Am J Obstet Gynaecol 1989; 161: 1200–204.CrossRefGoogle ScholarPubMed
4Redman, CWG. Platelets and the beginning of preeclampsia. Editorial. N Engl J Med 1990; 323: 478–80.CrossRefGoogle Scholar
5Visser, W, Wallenburg, HCS. Central hemodynamic observations in untreated preeclamptic patients. Hypertension 1991; 17: 1072–77.CrossRefGoogle ScholarPubMed
6Belfort, MA, Anthony, J, Saade, GR, Wasserstrum, N, Johanson, R, Clark, S et al. The oxygen consumption/oxygen delivery curve in severe pre-eclampsia: evidence for a fixed oxygen extraction state. Am J Obstet Gynaecol 1993; 169: 1448–55.CrossRefGoogle ScholarPubMed
7Shoemaker, WC. Prospective trial of supranormal values of survivors as therapeutic goals in high risk surgical patients. Chest 1988; 94: 1176–86.CrossRefGoogle ScholarPubMed
8Wallenburg, HCS. Hemodynamics in hypertensive pregnancy. In: Rubin, PC ed. Handbook of hypertension, volume 10. Elsevier, 1988: 66–101.Google Scholar
9Belfort, MA, Anthony, J, Kirshon, B. Respiratory function in severe gestational proteinuric hypertension: the effects of rapid volume expansion and subsequent vasodilatation with verapamil. Br J Obstet Gynaecol 1991; 98: 964–72.CrossRefGoogle ScholarPubMed
10Belfort, MA, Anthony, J, Buccimazza, A, Davey, DA. Verapamil in the treatment of severe gestational proteinuric hypertension. Obstet Gynaecol 1990; 75: 970–74.Google ScholarPubMed
11Vink, GJ, Moodley, J, Philpott, RH. Effect of dihydralazine on the fetus in the treatment of maternal hypertension. Obstet Gynecol 1980; 55: 519–22.Google ScholarPubMed
12Walters, BNJ, Redman, CWG. Treatment of severe pregnancy associated hypertension with the calcium antagonist nifedipine. Br J Obstet Gynaecol 1984; 91: 330–36.CrossRefGoogle ScholarPubMed
13Hulme, VA, Odendall, HJ. Intrapartum treatment of preeclamptic hypertension by Ketanserin. Am J Obstet Gynecol 1986; 155: 260–63.CrossRefGoogle ScholarPubMed
14Cotton, DB, Lee, W, Huhta, JC, Dorman, KF. Hemodynamic profile of severe pregnancy induced hypertension. Am J Obstet Gynecol 1988; 158: 523–29.CrossRefGoogle ScholarPubMed
15Benedetti, TJ, Cotton, DB, Read, JC, Miller, FC. Hemodynamic Observations in severe pre-eclampsia with a flow directed pulmonary artery catheter. Am J Obstet Gynecol 1980; 136: 465–70.CrossRefGoogle ScholarPubMed
16Spodick, DH. Analysis of flow directed pulmonary artery catheterization. JAMA 1989; 261: 1946–47.CrossRefGoogle ScholarPubMed
17Clark, SL, Horenstein, JM, Phelan, JP, Montag, TW, Paul, RH. Experience with the pulmonary artery catheter in obstetrics and gynecology. Am J Obstet Gynecol 1985; 152: 374–78.CrossRefGoogle ScholarPubMed
18Clark, SL, Cotton, DB. Clinical indications for pulmonary artery catheterization in the patient with severe pre-eclampsia. Am J Obstet Gynecol 1988; 158: 453–58.CrossRefGoogle Scholar
19Kirshon, B, Lee, W, Mauer, MB, Cotton, DB. Effects of low dose dopamine therapy in the oliguric patient with preeclampsia. Am J Obstet Gynecol 1988; 159: 604–607.CrossRefGoogle ScholarPubMed
20Oian, P, Maltau, JM, Noddeland, H. Transcapillary fluid balance in pre-eclampsia. Br J Obstet Gynaecol 1986; 93: 235–39.CrossRefGoogle ScholarPubMed
21Benedetti, TJ, Carlson, RW. Studies of colloid osmotic pressure in pregnancy induced hypertension. Am J Obstet Gynecol 1979; 135: 308.CrossRefGoogle ScholarPubMed
22Desai, DK, Bhorat, I, Moodley, J. Assessment of left ventricular structure and function in patients with pre-eclampsia complicated by pulmonary oedema. South African Hypertension Congress Meeting, March 1993.Google Scholar
23Herpolsheimer, A, Brady, K, Yancey, MK, Pandian, M, Duff, P. Pulmonary function of preeclamptic women receiving intravenous magnesium sulfate seizure prophylaxis. Obstet Gynecol 1991; 78: 241–44.Google ScholarPubMed
24Digre, KB, Varner, MW, Schiffman, JS. Neuroophthalmologic effects of intravenous magnesium sulfate. Am J Obstet Gynecol 1990; 163: 1848–52.CrossRefGoogle ScholarPubMed
25Weinstein, L. Syndrome of hemolysis, elevated liver enzymes and low platelet count: a severe consequences of hypertension in pregnancy. Am J Obstet Gynecol 1982; 142: 159–67.CrossRefGoogle ScholarPubMed
26de Jager, CA, Robson, SC, Kirsch, RE, Jacobs, P, Harvest, C, Dunne, T. et al. Serial measurements of circulating tissue plasminogen activator and fibrinogen degradation products predict outcome in gestational proteinuric hypertension. S Afr Med J 1993; 83: 898–99.Google ScholarPubMed
27Letsky, EA. Coagulation defects. In: de Swiet, M ed, Medical disorders in obstetric practice. London: Blackwell Scientific, 1989: 104–65.Google Scholar
28Neiger, R, Contag, SA, Couston, DR. The resolution of preeclampsia related thrombocytopenia. Obstet Gynecol 1991; 77: 692–95.Google ScholarPubMed
29Chandron, R, Serra-Serra, V, Redman, CWG. Spontaneous resolution of pre-eclampsia related thrombocytopania. Br J Obstet Gynaecol 1992; 99: 887–90.CrossRefGoogle Scholar
30Gamba, G. Acute thrombocytopaenias and thrombotic thrombocytopenic purpura: differential diagnosis. Transfusion Sci 1992; 13: 13–16.CrossRefGoogle Scholar
31Wallenburg, HCS. Personal communication.Google Scholar
32Verhaege, J, Anthony, J, Davey, DA. Platelet count and liver function tests in proteinuric and chronic hypertension in pregnancy. S Afr Med J 1991; 79: 590–94.Google Scholar
33Sibai, BM. Magnesium sulfate is the ideal anticonvulsant in preeclampsia-eclampsia. Am J Obstet Gynecol 1990; 162: 1141–45.CrossRefGoogle ScholarPubMed
34Robson, SC, Redfern, N, Seviour, J, Campbell, M, Walkinshaw, S, Rodeck, C. et al. Phenytoin prophylaxis in severe pre-eclampsia and eclampsia. Br J Obstet Gynecol 1992; 99: 554–56.Google Scholar
35Belfort, MA, Moise, KA, Saade, G. The effect of magenesium sulphate on maternal brain blood flow in mild pre-eclampsia: a randomized placebo controlled study. Am J Obstet Gynecol 1992; 167: 661–66.CrossRefGoogle Scholar
36Anthony, J, Belfort, MA, Johanson, R, Saade, G, Moise, K, Dommisse, J. The hemodynamic and respiratory effects of nimodipine in patients with eclampsia. Am J Obstet Gynecol 1993; 170: 412.Google Scholar
37Richards, AM, Moodley, J, Graham, DI, Bullock, MRR. Active management of the unconscious eclamptic patient. Br J Obstet Gynecol 1986; 93: 554–62.CrossRefGoogle ScholarPubMed
38Richards, AM, Graham, DI, Bullock, MRR. Clinicopathological study of neurological complications due to hypertensive disorders in pregnancy. J Neurosurg Psych 1988; 51: 416.CrossRefGoogle Scholar
39Allen, RW, James, MF, Uys, PC. Attenuation of the pressor response to tracheal intubation in hypertensive proteinuric pregnant patients by lignocaine, alfentanil and magnesium sulphate. Br J Anaesth 1991; 66: 216–23.CrossRefGoogle ScholarPubMed